NLRP3 and endothelial dysfunction: Considering that the causes related to endothelial dysfunction, oxidative stress, and inflammation in PE remain a challenge for clinical practice, the use of pharmacological substances related to the inhibition of the NLRP3 inflammasome may be a good choice to propose future treatments and strategies for PE.